OBM Neurobiology is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc. By design, the scope of OBM Neurobiology is broad, so as to reflect the multidisciplinary nature of the field of Neurobiology that interfaces biology with the fundamental and clinical neurosciences. As such, OBM Neurobiology embraces rigorous multidisciplinary investigations into the form and function of neurons and glia that make up the nervous system, either individually or in ensemble, in health or disease. OBM Neurobiology welcomes original contributions that employ a combination of molecular, cellular, systems and behavioral approaches to report novel neuroanatomical, neuropharmacological, neurophysiological and neurobehavioral findings related to the following aspects of the nervous system: Signal Transduction and Neurotransmission; Neural Circuits and Systems Neurobiology; Nervous System Development and Aging; Neurobiology of Nervous System Diseases (e.g., Developmental Brain Disorders; Neurodegenerative Disorders).
OBM Neurobiology publishes research articles, technical reports and invited topical reviews. Although the OBM Neurobiology Editorial Board encourages authors to be succinct, there is no restriction on the length of the papers. Authors should present their results in as much detail as possible, as reviewers are encouraged to emphasize scientific rigor and reproducibility.
Archiving: full-text archived in CLOCKSS.
Rapid publication: manuscripts are undertaken in 11.8 days from acceptance to publication (median values for papers published in this journal in the second half of 2021, 1-2 days of FREE language polishing time is also included in this period).
Current Trends in the Diagnosis and Management of Neuroleptic Malignant Syndrome
Submission Deadline: March 31, 2023 (Open) Submit Now
Dr. Varadaraj Velamoor
1. Professor of Psychiatry, Lakehead and Laurentian University, Canada
2. Professor Emeritus, Western University, Canada
3. Dr Velamoor has published over a hundred publications including book chapters and monographs. His work in the early diagnosis and management of Neuroleptic Malignant Syndrome in internationally recognized.
Research interests: suicide, violence, collaborative care, and traumatic brain injury; diagnosis of neuroleptic malignant syndrome
About This Topic
Neuroleptic Malignant Syndrome remains a dangerous condition with high morbidity and mortality. Although we now have a better understanding of the early diagnosis and management of this neurological disorder, we need to focus on the etiopathology to develop sound protocols for diagnosis and management. Emphasis on pharmacological and environmental variables with appropriate blood work and imaging standards will lead to safer outcomes for patients suspected of this diagnosis. We need to educate mental health care givers in better recognition and monitoring approaches to improve care and service to their patients.
This special issue is dedicated to focus on new advances and treatment by experts in the field. Their contributions will throw fresh light on this disorder and enable practitioners to gain confidence in their ability to understand and treat this condition safely.
To prevent robots and page crawlers from submitting fraudulent forms, complete verification to prove that you are a human.